1.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: EORTC-16008, GILEAD-110-10, OSI-EORTC-16008, NCT00022594
|
|
2.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 110-12, NCT00046787
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 110-20, NCT00046800
|
|
4.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: I138, CAN-NCIC-IND138, CAN-NCIC-11006, CDR0000068453, IND138, NCT00010179
|
|
5.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: I123, CAN-NCIC-IND123, NEXSTAR-110-02, CDR0000067060, IND123, NCT00003891
|
|
6.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: I133, CAN-NCIC-IND133, NEXSTAR-110-05, CDR0000068051, IND133, NCT00006036
|